Categories
Health

Some Aged African Individuals Are Hesitant In regards to the Covid Vaccine

BATON ROUGE, La – Flossie West was not at all interested in taking the coronavirus vaccine.

Carla Brown, the nurse who oversaw her care, was determined to change her mind.

Ms. West, 73, has ovarian cancer, heart failure and breathing difficulties – conditions that put her at serious risk if she contracts the virus. As it is, Covid-19 has killed far too many of its neighbors in Mid-City, a low, predominantly black community that is spreading east of the state capital of Louisiana.

But Ms. West’s skepticism about the new vaccines overshadowed her concerns about Covid-19. “I’m just not interested because everyone is telling me the virus is a joke,” Ms. West said. “And besides, this shot will make me sicker than I already am.”

On Thursday morning, Ms. Brown, 62, came to Ms. West’s apartment and gave a stern lecture: The virus is real, the vaccines are harmless, and Ms. West should get out of bed, take her oxygen tank and get into her car.

“I’ll be damned if I let this coronavirus take me away,” she said.

For the past few weeks, Ms. Brown has worked frenetically to get her patients to vaccinate, and her one-woman campaign provides insight into the barriers that have contributed to worryingly low vaccination rates in the black community.

Even if the vaccine supply continues to grow, African Americans will be vaccinated with half of whites, according to an analysis by the New York Times. The differences are particularly alarming given the disproportionate impact of the pandemic on color communities, who have died twice as often as whites.

The racial divide in vaccination rates is no less great in Louisiana, where African Americans make up 32 percent of the population but only 23 percent of those vaccinated.

Part of the problem is access. In Baton Rouge, most of the mass vaccination stations are located in white areas of the city, creating logistical challenges for older and poorer residents in black neighborhoods like Mid-City, who often have no access to transportation. Older residents have also been thwarted by online appointment systems, which can be daunting for those without computers, smartphones, or fast internet connections.

Experts say much of the racial differences in vaccination rates is due to African Americans’ longstanding distrust of medical facilities. Many Baton Rouge residents can easily quote the history of abuse: from the eugenics campaigns, in which black women were forcibly sterilized for almost half of the 20th century, to the infamous government-run Tuskegee experiments in Alabama that involved hundreds was withheld penicillin from black men with syphilis, some of whom later died of the disease.

“Suspicion among black Americans comes from a real place and pretending that it doesn’t exist or questioning whether it’s rational is a recipe for failure,” said Thomas A. LaVeist, health justice expert and dean of the school of Public Health and Tropical Medicine from Tulane University. Dr. LaVeist has advised officials in Louisiana on ways to increase vaccination rates.

Ms. Brown, 62, the hospice nurse, has a good idea how to change the minds of vaccine skeptics: Encouraging one-on-one meetings with distinguished black community figures who can address concerns and provide reliable information while acknowledging what you describe as the scars of inherited trauma. “If you look back on our history, we have been lied to and there has been a lot of racial pain so it’s about building trust,” she said.

Updated

March 6, 2021, 4:46 p.m. ET

It also helps if she tells people that she has already been vaccinated.

As a Covid survivor, Ms. Brown has become a whirling dervish cruiser against the hesitation of vaccines in Baton Rouge. Your sense of mission is fueled in part by personal loss. Last May, while working as a hospital psychiatric nurse, Ms. Brown unwittingly brought the coronavirus into her home. Her husband, son, and 90-year-old father all became seriously ill and ended up in the hospital. Her husband, a cancer survivor whom she referred to as “the love of my life,” ended up on a ventilator. He died in July.

With a newfound determination to care for the most vulnerable patients, she quit her job at the hospital and started working with terminally ill people in January last year.

“My husband couldn’t get the vaccine, but I’ll be damned if I don’t vaccinate everyone around me,” she said. “I don’t care if you’re homeless. When I come to you, you get in my car. “

She went into high gear on Thursday after learning that a pop-up vaccination center in East Baton Rouge had dozens of doses available.

Ms. Brown prefers to personalize her parking space, but less than three hours before the site was due to close, she pulled her cherry-red Toyota Scion into the Hi Nabor supermarket parking lot, took out her cell phone, and opened a thick folder with contact information for it the 40 patients she manages as Nursing Director at Canon Hospice, a palliative care provider in Baton Rouge.

“Is that Miss Georgia?” She asked. “Have you already got the Covid shot? No? Then get dressed because we’re coming to get you. “

What you need to know about the vaccine rollout

There were several refusals – “I’m still not convinced it’s safe,” said one woman – but in less than an hour she had five people persuaded to get vaccinated.

She then called the East Baton Rouge Council on Aging, the nonprofit group that runs the vaccination site, and asked them to ship some of their vans.

In addition to organizing the transport, Tasha Clark-Amar, the organization’s managing director, tries to overcome the logistical hurdles by making appointments by telephone and letting the employees fill out the necessary documents in advance. Next week she hopes to send teams of health workers to vaccinate 4,000 residents across the city who are bedridden.

Ms. Clark-Amar is also driven by a sense of urgency: In the past year, more than 140 of her customers died of Covid-19. Her strategy of winning over the hesitant is no different from Mrs. Brown’s, though she often seeks to appeal to the guidance and respect commanded by the elders in the black community. “I tell them, ‘You are the matriarch or patriarch in the family and you should lead by example,” she said. If that doesn’t work, she’s more dull, “At your age, it’s the vaccine or the grave.”

Less than 30 minutes after Ms. Brown spoke on the phone, a housekeeper, Dorothy Wells, rolled into the brightly lit cafeteria of the senior citizen center. Ms. Wells, 84, a stroke patient, had initially refused to be vaccinated but was overruled by her son.

Ms. Wells’ aide, Rashelle Green, 45, was also reluctant to get vaccinated. She shared stories she read on social media about people who got sick or died after receiving the gunshots, despite health officials saying side effects from the coronavirus vaccine are extremely rare.

But after Ms. Green saw people being vaccinated and walked out after 15 minutes of observation, she changed her mind. As she waited for her turn, she jumped nervously up and down. When it was time to roll up her sleeve, she winced but barely noticed the needle prick. “That wasn’t bad at all,” she said.

Then there was Ms. West, the cancer patient whose house Ms. Brown had visited earlier that day. For the past year, Ms. West, who lives alone and has no children, has been looking forward to twice-weekly checkups with Ms. Brown. Aside from the occasional appointment with her oncologist, her visits are roughly the only time that she has personal contact with another person. “I feel like Ms. Brown really cares about me,” she said.

Given the deep trust that had been cultivated over the past few months, it was not long before Mrs. Brown won her over.

Ms. West was sitting in the surveillance area of ​​the vaccination center on Thursday and said she was glad she listened. “When I get home,” she said, “I’ll text all of my friends and tell them to get the shot.”

Categories
Health

Detroit mayor rejects preliminary J&J vaccine cargo, calls Pfizer, Moderna ‘the very best’

Vial of the Janssen Coronavirus Disease (COVID-19) vaccine from Johnson & Johnson

Johnson & Johnson via Reuters

Detroit Mayor Mike Duggan turned down an initial allocation of the Johnson & Johnson Covid-19 single vaccine this week, according to the Michigan State Department of Health.

At a news conference Thursday, Duggan confirmed that he had refused to grant J&J vaccines from the state this week, citing sufficient supply of Pfizer and Moderna vaccines to meet demand from eligible residents.

“Johnson & Johnson is a very good vaccine. Moderna and Pfizer are the best. And I’ll do everything I can to make sure the Detroit city residents get the best,” Duggan said at a news conference Thursday.

The FDA on Saturday approved J & J’s Covid-19 vaccine for emergency use. This makes it the third vaccine approved for distribution in the United States and the only vaccine that requires only one dose.

Clinical trial data shows that J & J’s vaccine provides 66% overall protection against Covid, compared to around 95% for Pfizer and Moderna vaccines. While some have raised concerns about the J&J vaccine’s lower rate of effectiveness, the J&J vaccine has been shown to prevent 100% of virus-related hospitalizations and deaths, according to clinical trial data.

“All vaccines are safe and effective, and I recommend that all vaccines be offered in all communities,” said Dr. Michigan chief medical executive Joneigh Khaldun in a statement to CNBC.

“Also, the Johnson and Johnson vaccine has been studied in a more recent period of time with more easily transmissible variants, so I would not recommend comparing the Pfizer and Moderna studies directly with the Johnson and Johnson studies,” Khaldun said.

At a news conference on Friday, Andy Slavitt, Senior White House Covid Advisor, said Duggan’s comments on the J&J vaccine had been misunderstood.

“We have had a constant dialogue with Mayor Duggan … He is very excited about the Johnson & Johnson vaccine. And I think we want to reiterate the message that the very first vaccine we can take makes perfect sense for all of us is take, “said Slavitt.

In a statement later Friday, Duggan reiterated the effectiveness of the J&J shot in preventing hospitalizations and Covid-related deaths.

“The only reason we decided not to take the first shipment from Johnson & Johnson was because we had the capacity with Moderna and Pfizer to handle the 29,000 first and second dose appointments planned for the coming week which has already brought us very close to our capacity at our current locations, “Duggan said in a statement on Friday.

The J&J allotment, rejected by Duggan, comprised 6,200 doses that were distributed to other local Michigan health departments, according to Bob Wheaton, spokesman for the state health department.

Wheaton said the state doesn’t expect to receive any more J&J vaccines “for a few weeks.”

Duggan said the city will open a new vaccination site for J&J shots if demand from eligible residents exceeds supply of Moderna and Pfizer cans.

“We always planned to distribute Johnson & Johnson as soon as demand warranted it, and we had our distribution plan so we could make it available to our residents as much as Moderna and Pfizer,” Duggan said in Friday’s statement. “By the time the next J&J broadcast arrives, we’ll have our plan to make it available.”

Categories
Health

Some LGBTQ Folks Are Saying ‘No Thanks’ to the Covid Vaccine

To date, around 54 million people in the United States have received at least one dose of a Covid-19 vaccine, of which nearly 28 million have been fully vaccinated. At Callen-Lorde and other medical centers that treat many LGBTQ patients, health care workers have reported higher demand for the vaccine in white patients than in those with skin color.

According to a study by the Williams Institute published in February, LGBT people of color were twice as likely to test positive for Covid-19 as non-LGBT white people. Although blacks are at higher risk of contracting the disease, experts say that this population is particularly concerned about the vaccine. In a study published this month in Vaccines magazine, 1,350 men and transgender women who were predominantly identified as gay or bisexual reported the likelihood of receiving a Covid-19 vaccine. The black participants expressed significantly more vaccine reluctance than their white counterparts, according to the study.

Healthcare workers face the same resistance from their patients. “Some people just said literally, ‘Well, no – Trump was involved in getting this vaccine going, so I’m not going to get the vaccine,” said Jill Crank, a nurse at Johns Hopkins Community Physicians in Baltimore.

Studies show that all population groups, including those in the medical profession, have concerns about the Covid vaccine. According to a survey published in December by KFF (formerly Kaiser Family Foundation), about three in ten healthcare workers are reluctant to get the vaccine, compared to about a quarter of the general population.

Dezjorn Gauthier, 29, a black transgender man who lives about 20 minutes from Milwaukee, said that while he can’t get the vaccine, he doesn’t want it.

“It’s a no-go at the moment,” said Gauthier, a model and business owner who has Covid-19 antibodies because he contracted the coronavirus last year. The vaccine has been developing “so fast and so fast that I am just a little hesitant,” he said, adding that he was also unsure of the vaccine’s ingredients. “There is a fear in the church.”

Updated

March 5, 2021, 2:50 p.m. ET

For members of the LGBTQ community, and especially for people of color, the hesitation is partly due to the already existing distrust of the medical facility, according to the experts.

Categories
Health

San Diego Zoo Apes Get an Experimental Covid Vaccine

The San Diego Zoo gave nine monkeys an experimental coronavirus vaccine developed by Zoetis, a large veterinary drug company.

In January, a group of gorillas in the zoo’s Safari Park tested positive for the virus. Everyone is recovering, but the Zoo asked Zoetis for help vaccinating other monkeys. The company provided an experimental vaccine that was originally developed for pets and is now being tested in mink.

Nadine Lamberski, conservation officer and animal health officer at San Diego Zoo Global, said the zoo vaccinated four orangutans and five bonobos with the experimental vaccine, which is not intended for use in humans. Among the orangutans vaccinated was a monkey named Karen, who made history when she became the first orangutan to undergo open heart surgery in 1994.

Dr. Lamberski said a gorilla in the zoo should also be vaccinated, but the gorillas in the wildlife park had a lower priority because they had already tested positive for infections and had recovered. She said she would vaccinate the gorillas in the wildlife park when the zoo received more doses of the vaccine.

Mahesh Kumar, senior vice president of global biologics at Zoetis, said the company is increasing production, largely due to the pursuit of a license for a mink vaccine, and will provide more doses to San Diego and other zoos if possible. “We have already received a number of inquiries,” he said.

Infection in monkeys is a major concern for zoos and conservationists. They are easily susceptible to human respiratory infections and the common cold virus has caused fatal outbreaks in chimpanzees in Africa. Genomic research has shown chimpanzees, gorillas and other monkeys are susceptible to SARS-CoV-2, the virus that caused the pandemic. Laboratory researchers use some monkeys, like macaques, to test drugs and vaccines and develop new therapies for the virus.

Updated

March 5, 2021, 8:37 a.m. ET

Scientists are concerned not only about the threat the virus poses to great apes and other animals, but also about the potential of the virus to enter a wildlife population that could become a permanent reservoir and emerge at a later date around the world Re-infecting people.

Infections with mink farms have caused the greatest horror so far. When Danish mink farms were destroyed by the virus, which can kill mink as well as humans, a mutated form of the virus emerged from the mink and re-infected people. This variant has shown resistance to some antibodies in laboratory studies, suggesting that vaccines may be less effective against them.

According to the World Health Organization, this virus variant has not been found in humans since November. However, other variants have emerged in people in several countries, proving that the virus can become more contagious and, in some cases, affect the effectiveness of some vaccines.

Denmark killed up to 17 million minks, wiping out its mink farming industry. Thousands of minks have died in the United States, and one wild mink tested positive for the virus.

Although many animals, including dogs, domestic cats, and big cats in zoos, have been infected with the virus through natural spread and others have been infected in laboratory experiments, scientists say widespread testing has found the virus in no animal in any animal other than the one mink .

National Geographic first reported on vaccinating the monkeys at the San Diego Zoo.

Categories
Health

Will I would like proof of vaccine to journey overseas?

As the adoption of vaccinations gains momentum around the world, attention is now turning to vaccines of a different kind: vaccination records.

Last week, the International Air Transport Association announced the launch of its new digital passport as a “way forward” for the resumption of quarantine-free international travel.

The app, which is being tested by 30 airlines, enables governments and airlines to collect, access and share encrypted information related to the passengers’ Covid-19 test and vaccination status before departure.

The International Chamber of Commerce and the World Economic Forum have developed similar apps – ICC AOKpass and CommonPass – that travelers can use to electronically document their medical status. Countries like Denmark and Sweden are introducing their own health passports, and even tech giants want to join.

What are digital health passes and will they allow a return to heaven this year?

What is a vaccination certificate?

A vaccination card, also known as a digital health card, is digital documentation that a person has been vaccinated against a virus, in this case Covid.

Stored on a phone or digital wallet, the data is usually presented as a QR code and can also indicate whether a person has tested negative for a virus.

Digital health passports are tested to validate people’s Covid-19 test and vaccination status.

Maskot | Getty Images

Such documentation is not unprecedented. For decades, people traveling to certain countries have had to show physical “yellow cards” as proof of vaccination against diseases such as cholera, yellow fever and rubella.

However, this is the first time the industry has advocated an electronic alternative to improve auditability and bypass some of the delays caused by paper peers.

“Imagine the scene when 180,000 people present a piece of paper that needs review and validation,” said Mike Tansey, general manager at Accenture, referring to the number of daily passengers at Changi Airport in Singapore prior to Covid.

Do we need digital health passes to travel?

Tansey, who leads Accenture’s APAC Travel and Hospitality division, has worked with several major airlines on their digital health passport strategies, including three in the US and several in the Asia-Pacific region.

He told CNBC’s Global Traveler that these plans have “accelerated” since the vaccine was launched, and the need for such IDs is clear to him.

The obvious answer is yes we do.

Mike Tansey

General Manager, Travel and Hospitality, Accenture

“The obvious answer is’ yes,” Tansey said when asked if we would need digital health cards to resume the trip.

He called debates a “red herring”.

“Governments may not say you have to have one, but the effects of not will be so ridiculous that travel isn’t worth it,” he said, referring to extensive testing and “draconian” quarantines.

What are the security concerns?

Tansey is not alone. Other experts agree that digital health passes are the fastest, most effective way to resume international travel.

Jase Ramsey, professor of management at Florida Gulf Coast University’s Lutgert College of Business, agreed that the likelihood of adoption was “very high”. However, he noted that concerns about security and personal information could make consumers less willing to use digital health passports than their physical alternatives.

“As with any app that stores health records, there are privacy and fraud concerns,” said Ramsey.

Vaccination records electronically store medical information that is displayed as a QR code.

da-kuk | E + | Getty Images

Accredify is a Singapore-based document accreditation firm whose technology is used as part of the Singapore government mandated Covid-19 pre-travel health screening. It is claimed that the appeal of digital accreditation systems – like its own, which is based on the blockchain – is that they are tamper-proof and therefore cannot be forged.

“Medical documents that are privately and securely stored in the app are only accessible to users, so they can decide who and when to share their medical records with,” a spokesman said via email.

Traveler resistance can be overrated. A recent study by travel news website The Vacationer found that 73.6% of Americans surveyed would use a Covid health pass or app so airlines and border agencies can check their vaccination status and test results.

What are the challenges for health passports?

The success of digital health passports depends on the effectiveness of vaccines. Little is known about whether vaccines prevent the spread of Covid, although research is currently being carried out.

The World Health Organization has urged caution with health cards and urged the authorities and tour operators not to introduce proof of vaccination as a condition for international travel.

The effectiveness of vaccines in preventing transmission is not yet clear and global vaccine supplies are limited.

speaker

World health organization

“This is because the effectiveness of vaccines in preventing transmission is not yet clear and global vaccine supplies are limited,” said a WHO spokesman.

Coordinating the various existing and pending vaccination records in the market and ensuring that users’ certifications are linked to verified and approved medical facilities will prove to be a major challenge.

“For vaccine passports to be an internationally practical tool, there must be a standardized platform that crosses all borders – like the current passport system,” said Dr. Harry Severance, Assistant Professor at Duke University School of Medicine.

WHO works with agencies such as the International Air Transport Association and the International Civil Aviation Organization to develop standards for digital vaccination cards. It added that its position on health passports “will evolve as the evidence for existing and new Covid-19 vaccines is updated”.

What about the social impact?

Add to this, of course, the social, legal and political implications of a system based on unequal global access to vaccines and technology.

According to the WHO, around 3.6 billion people worldwide cannot access the Internet and more than 1.1 billion cannot officially prove their identity. For many, paper IDs remain essential.

Access to vaccinations is still far from fair around the world

Luis Alvarez | DigitalVision | Getty Images

“People from different countries, regions or communities may not have access to vaccines or Covid-19 tests,” said Dr. Sharona Hoffman, a bioethics professor at Case Western Reserve University’s School of Medicine, noting that low-income countries may not get vaccinations until 2023 or beyond. “Policies that prevent them from traveling or using other services could be discriminatory and exacerbate socio-economic disparities.”

Such systems could also set a precedent for other groups that are also eager to reopen, such as B. Restaurants and Event Venues. In fact, Israel has already created a “green passport” to give vaccinated citizens access to public venues.

This week, some US states decided to lift mask mandates, which could exacerbate this problem.

“As one community moves in this direction, many, many more will follow. As decisions like this are made across the country, you may find that ‘carding’ vaccines becomes the standard,” Severance said.

What could this mean for the future of travel?

Ultimately, resumption of international travel will depend as much on countries’ willingness to reopen as it does on existing travel verification technology.

In the Asia-Pacific region, where borders remain largely closed to tourists, governments may lean towards bilateral agreements or “travel bubbles” with select neighbors before opening further, Accenture’s Tansey said.

An internationally recognized system of health passports … will potentially enable us to survive an impending pandemic.

Harry Severance

Duke University School of Medicine

“The The reality … is that we are six months away from meaningful air travel, “he said.” Agreements are only made with one or two locations at a time. “

However, with much of the technology in place and society moving towards an increasingly digitized future, today’s developments in digital health passports could better prepare the travel industry – and society – for potential turmoil.

“As we evolve into an internationally recognized system of monitoring health passports (or) etc, it will be a facet of a downstream preparedness system that may allow us to survive an impending pandemic that may have worse dynamics than Covid- 19. ” “said Severance.

Categories
Business

Troops who decide out of Covid vaccine are ‘a part of the issue’

A paratrooper assigned to the 82nd Airborne Division’s 1st Brigade Combat Team prepares for an airborne operation May 7 at Fort Bragg, NC.

Spc. Hubert Delany III | US Army

WASHINGTON – The White House Chief Medical Officer, Dr. Anthony Fauci said Thursday that U.S. service members who are eligible to receive the Covid-19 vaccine but opt ​​out are inadvertently “part of the problem” of the pandemic’s extension.

“You are part of the solution to this outbreak,” Fauci told a virtual audience during a town hall with Blue Star Families, a nonprofit that addresses issues facing military families.

“Because through an infection, although you may not know it, you may accidentally pass the infection on to someone else even though you have no symptoms,” said Fauci. “In reality, like it or not, you are spreading this outbreak. Instead of being part of the solution, you are innocent and inadvertently part of the problem by not getting vaccinated.”

“You have to think about your own health, which is really very important, but you have to think about your social responsibility, including people you are personally close to as well as other family members of other people,” said Fauci.

Last month, the Pentagon admitted that about a third of U.S. military service members refused to take the voluntary coronavirus vaccine.

U.S. Marine Corps Staff Sgt.Felicia White, a supervisor at Camp Kinser Post Office, has her arm disinfected to receive her second dose of the COVID-19 vaccine at U.S. Naval Hospital Okinawa on March 2, 2021 at Camp Foster.

U.S. Marine Corps Lance Cpl. Zachary Larsen | US Marine Corps

When asked if the military leadership was disappointed with the revelation, Pentagon spokesman John Kirby told reporters last month that the decision to take the vaccine is ultimately up to each member of the force.

“Everyone is different and we want – what the secretary wants – the men and women in the department to make the best and most informed decisions for them and for their health and the health of their families,” said Kirby, adding to Secretary of Defense Lloyd Austin got the vaccine.

Meanwhile, the U.S. Northern Military Command, responsible for the Pentagon’s coronavirus efforts, has hired thousands of service members to help vaccinate communities across the country.

Last week Austin began his first official trip since rising to the top of the Pentagon to meet with military commanders overseeing the Covid-19 response effort in California.

Austin also visited a FEMA vaccination center in Los Angeles, the first to be manned by both active military teams and National Guard personnel.

Active Duty Soldiers and the Army National Guard prepare to receive a sham vaccine recipient during an exercise at California State University in Los Angeles on February 14, 2021.

US Army Capt. Daniel Parker | US Army

Austin said the Pentagon was committed to relaying factual information to the armed forces in order to build trust.

“There is a certain amount of suspicion and I think we have to work hard together to dispel rumors and provide facts to people,” Austin told reporters who travel with him. “And my experience is that when people are armed with the facts, they tend to make the right decisions.”

“My advice to everyone is, I mean, this saves lives. And it’s not just about saving our lives, it’s about saving the life of our partner, the neighbor, and in the military we live from teamwork and we have to think You also to our teammates, “he added.

Categories
Health

One and Executed: Why Folks Are Looking forward to Johnson & Johnson’s Vaccine

In North Dakota, health officials this week are sending their first Johnson & Johnson Covid-19 vaccines to pharmacies and emergency clinics where people who don’t necessarily have a regular doctor can get the only push. In Missouri, cans are dispensed to community health centers and rural hospitals. And in North Carolina, health care providers use it to vaccinate meat packers, farm and food workers.

Ever since Johnson & Johnson revealed data showing that its vaccine, while very protective, had a slightly lower rate of effectiveness than the first shots made by Moderna and Pfizer-BioNTech, health officials have feared that the new shot might be considered by some Americans as the could be considered worse choice.

But the early days of the rollout suggest something else: some people are excited to get it because they want the convenience of a single shot. And public health officials are excited about how much faster they can distribute a single shot, especially in vulnerable communities that may otherwise not have access to a vaccine.

“This is a potential breakthrough,” said Dr. Joseph Kanter, the chief health officer in Louisiana. With its first allotted doses, the state is hosting a dozen large Johnson & Johnson vaccination events in community centers and other public places, modeled on flu vaccines.

As Johnson & Johnson’s production grows over the next several months, Dr. Kanter, the shot would allow his state to cut the staff and surgery costs associated with the second dose: “The J&J vaccine brings a lot to the table.”

In terms of how well it prevents serious illness, hospitalizations, and deaths, the Johnson & Johnson shot is comparable to that of Moderna and Pfizer-BioNTech. And while there is a lower overall effectiveness rate in the U.S. – 72 percent compared to around 95 percent in the others – experts say comparing these numbers is problematic because the companies’ studies were conducted at different times in different locations.

The Johnson & Johnson vaccine can also be stored at normal refrigerated temperatures for three months – ideal for distribution in non-medical locations such as stadiums and convention centers.

“There are circumstances when this will be a really good, or perhaps the best, option,” said Dr. Matthew Daley, senior investigator at Kaiser Permanente Colorado’s Institute for Health Research and member of the Centers for Disease Control and Prevention Independent Vaccine Advisory Board.

Only four million cans have been shipped this week, and the company’s production delays mean it will be at least a month before the states receive significant shipments. Because of this loophole, state officials are treating the first wave of doses as a moment to test different ways it can be used.

Patrick Allen, the director of the Oregon Health Authority, said the first doses in the state went to various facilities “to see if we could learn from their use.” This included mass vaccination sites in the Portland area, adult nursing homes, and pharmacies not included in the federal government’s pharmacy program. Health officials will evaluate the success of each of these locations to develop a plan for the larger shipments.

Many state health officials said they were focused on getting the vaccine to people who may be harder to reach for a second dose, such as the homeless or about to be released from prison. In North Carolina, this category includes the state’s mobile farming communities with three- or four-week working seasons. Mandy Cohen, the state’s health secretary, said large meat packers in the state such as Smithfield and Tyson Foods were interested in Johnson & Johnson’s vaccine and had consulted with their department.

And because the vaccine tends to have fewer side effects than the other options, it appeals to people who don’t want to risk missing a work day to recover from chills or a fever. She said, “There are a lot of people who are. For example,” I’m much more interested now that you tell me I only need to get one shot instead of two. “

“I don’t think it’s an inferior vaccine, so I’m taking it for myself,” said Ms. Cohen, who was supposed to get the shot from Johnson & Johnson on Friday.

The vaccine has caused a stir in small, independent pharmacies. Steve Hoffart, the owner of Magnolia Pharmacy in Magnolia, Texas, a small town outside of Houston, has received calls and emails from residents waiting to arrive this week. He hopes to hold a Johnson & Johnson teacher event on March 13th. Schools in the area struggled to find replacement teachers during the pandemic, and a vaccine that doesn’t require a second visit and more free time has been a significant development. he said.

Tim and Joyce Staab, who live in Chillicothe, Ohio, a town about 20,000 hours’ drive from Columbus, were two of the first Americans to receive the Johnson & Johnson vaccine. Both had general vaccination appointments scheduled for later in the week. But then they learned on Wednesday that an independent pharmacy near them had received 100 doses of Johnson & Johnson’s shot. Ms. Staab, 68, hesitates with needles and liked the one-and-do approach.

Mr Staab, 67, said he thought the vaccine would be a better choice for healthcare providers like the pharmacy where he got it. “You don’t have the resources, I don’t think, to deal with really hard-to-store vaccines,” he said.

States were able to adjust and craft distribution plans, in part because the federal government did not issue guidelines on where and to whom the vaccine should go.

That winter, as the Food and Drug Administration’s approval of the Johnson & Johnson vaccine approached, federal officials involved in vaccine distribution pushed for a more centralized use of the shot, either at large stadiums or at mass vaccination sites, which operated by the Federal Emergency Management Agency or only at pharmacies, according to officials familiar with these discussions. However, the White House preferred to allow states to tailor their own plans, as they had for the Moderna and Pfizer-BioNTech vaccines.

While health professionals are excited about the potential public health benefits of the new vaccine, some also fear that once vaccines run out, public interest will wane. When some people have a choice of brands, they may reject Johnson & Johnson’s, viewing it as an inferior choice.

In the mid-Atlantic black churches, Darrell J. Gaskin, professor of health policy at Johns Hopkins University and pastor, and Rupali Limaye, scientist at the university studying vaccine reluctance, have advised and reassured hundreds of people pastors and parishioners in Africa Methodist Episcopal Zion Churches in virtual presentations highlighting the safety of the Johnson & Johnson vaccine and the prevention of major Covid-19 and death, including among the black volunteers at the company’s trial.

Dr. Gaskin said it was vital for officials to highlight the benefits of the vaccine at the beginning of its distribution so that people “don’t feel like there’s a luxury vaccine and then the non-luxury vaccine”.

“We are facing differences when it comes to Covid,” said Dr. Limaye. “How do we reduce differences? We bring out a product that contains a dose and is stable. “

One of the members of the Church of Dr. Gaskin, Patricia Cooper, a teacher in Washington, DC, said President Donald J. Trump’s efforts to get a vaccine approved last year and the “Emergency Use Approval” label suggested that the federal government could I’ve rushed reviews of vaccines and made them nervous about their safety. But she said she was eager to get a vaccine, particularly from Johnson & Johnson.

“This one is more appealing to me,” she said. “Who likes to get stuck more than once?”

But Oregon health officer Mr. Allen warned that a more specific use could lead to skepticism about its quality.

“When you start getting a little too cute, when you specifically target its use, you may feed the distrust of, ‘Well why am I getting this vaccine? And I’m in that particular population and people who aren’t in that particular population aren’t getting this vaccine, ”he said.

Federal health officials have promised a way to crack down on the Johnson & Johnson vaccine, which may be used in unequal ways. Dr. Marcella Nunez-Smith, chair of the Biden administration’s new Health Justice Task Force, told a press conference at the White House this week that the vaccine distribution “should be evenly distributed among communities.”

“We’ll be tracking biometrics like zip code and social vulnerability to see where the vaccines are going,” she said. “And if certain vaccines are consistently delivered to certain communities, we can intervene.”

Some state officials believe pairing the new and old vaccines can help show that they are equally important.

Mr Allen said Oregon has similar sales plans for Johnson & Johnson and Moderna because both vaccines can be refrigerated for short term. The state treats the Pfizer BioNTech vaccine as the vaccine with “special considerations” as it has stricter shipping requirements and large packs of vials that are better suited for mass vaccination sites, he said.

Managing Johnson & Johnson and Moderna vaccines in a similar manner would help “avoid equity issues and potential concerns based on perceived differences between vaccines, some of which are real and some of which are not”.

Categories
Health

Italy blocks shipments of AstraZeneca Covid vaccine

Vial of AstraZeneca vaccine against coronavirus (COVID-19) on the first day of a mass vaccination by police and fire departments at the Wanda Metropolitan Stadium.

Marcos del Mazo | LightRocket | Getty Images

LONDON – The European Union intervened in the supply of coronavirus vaccines for the first time. Italy reportedly blocked delivery of the AstraZeneca-Oxford vaccine to Australia on Thursday.

Reuters, citing two sources, reported that the British pharmaceutical company AstraZeneca had asked Rome for permission to ship around 250,000 doses from its plant in Anagni, Italy. However, the Italian government refused. The Financial Times also reported the same story.

An AstraZeneca spokesman declined to comment when contacted by CNBC. A spokesman for the EU or the Italian Foreign Ministry was not immediately available to comment.

In January, the European Union temporarily controlled exports of vaccines made within the bloc after AstraZeneca and other supply problems were spat at. The EU has been under pressure from what critics are calling the slow adoption of Covid vaccines.

The European Commission, the body that runs the sales contracts, has been accused of not securing enough vaccines and the region’s medical agency has been criticized for taking too long to approve vaccinations that have given the go-ahead elsewhere have received.

The controls will last until the end of March and give EU member states the power to refuse to authorize exports if vaccine manufacturers fail to comply with contracts.

In January, AstraZeneca announced that it would deliver far fewer cans to the EU than originally expected in the spring due to production problems at its plants in the Netherlands and Belgium. Then on January 31, it announced it would dispose of an additional 9 million doses in the first quarter to make up for the deficit.

Categories
Health

Charts present how Pfizer’s vaccine is working

1.8 ml sodium chloride is added to a vial of Pfizer / BioNTech COVID-19 vaccine concentrate ready for administration at Guy’s Hospital at the start of the largest vaccination program in UK history on December 8, 2020 in London, UK.

Victoria Jones – Pool | Getty Images

LONDON – New data from England has shown how effective coronavirus vaccines are in fighting the disease, even after just one dose.

In December, the vaccine developed by Pfizer and BioNTech became the first vaccine to be approved and launched in the UK

The elderly, health workers and nursing home workers were the first to be vaccinated. This was soon followed by the shot developed by the British company AstraZeneca and the University of Oxford, another vaccine that requires two doses.

Infection control

Figures in a research report by Public Health England released Monday, but pending peer review, showed Pfizer and Oxford-AstraZeneca vaccines are highly effective in reducing Covid infections in people aged 70 and over.

Since the study began in January, protection against symptomatic Covid four weeks after the first dose has ranged between 57% and 61% for the Pfizer vaccine and between 60% and 73% for the AstraZeneca vaccine.

The effectiveness of the vaccine in the data for Public Health England is calculated using a mathematical ratio. Click here for full data and methods.

Reduce hospital stays and deaths

The study, which included data from over 7.5 million people, also found that a single dose offered additional protection against hospitalizations and death.

It is said that coronavirus cases in vaccinated people had about half the risk of severe outcomes compared to non-vaccinated cases. It combined this with estimates of their effectiveness against symptomatic disease and predicted that a single dose of either vaccine would be about 80% effective in preventing hospitalization in the elderly about three to four weeks after the first dose.

It has also been suggested that a single dose of the Pfizer vaccine is 85% effective in preventing death from Covid-19 in those over 80.

British Health Secretary Matt Hancock called the results “very strong”.

“They could also help explain why the number of Covid ICU admissions for people over 80 in the UK has dropped to single digits in recent weeks,” he said.

UK policymakers feel vindicated after deciding to postpone the second dose to around three months in order to vaccinate more people with a first dose faster. Experts in the US hesitated with the strategy, and White House chief medical officer Dr. Anthony Fauci said Monday that “there are risks on both sides”.

As of Sunday, 20,275,451 Brits have received their first dose of vaccine and 815,816 have received both doses, government data said.

The UK vaccination program was widely hailed as a triumph amid tragedy. The UK has the fifth highest number of infections in the world after the US, India, Brazil and Russia, with nearly 4.2 million infections and over 123,000 deaths. This is the fifth highest number of deaths in the world, according to Johns Hopkins University.

—CNBC’s Bryn Bache contributed to this article.

Explanation: This story has been updated to better reflect the vaccine effectiveness calculations.

Categories
Health

Biden Vows Sufficient Vaccine ‘for Each Grownup American’ by Finish of Could

However, Johnson & Johnson and its partners lagged behind making them. The company was supposed to be dropping off its first 37 million cans by the end of March, but said it could only drop 20 million cans up to that date, making Biden’s aides nervous.

In late January, Jeffrey D. Zients, Mr. Biden’s coronavirus response coordinator, and Dr. David Kessler, who manages vaccine distribution for the White House, to senior company officials including Alex Gorsky, whose executive director sent blunt message: This is unacceptable.

This resulted in a series of negotiations in February during which administration officials repeatedly pressured Johnson & Johnson to accept that they needed help and, according to two administration officials involved in the discussions, called on Merck to be part of the solution.

In a statement on Tuesday, Merck said the federal government would pay up to $ 269 million to customize and provision existing facilities to manufacture coronavirus vaccines. Michael T. Nally, executive vice president of human health at Merck, said in an interview that the company has had discussions with several companies and governments, including representatives of the former Trump administration.

“I think we all realize that every day counts,” he said.

Mr Nally declined to provide an estimate of the number of doses of vaccine the company could ultimately produce, saying only that it would be “significant”. However, the expanded range from Merck will probably only be available after months.

A federal official, speaking on condition of anonymity, said other steps the administration was taking would extend Johnson & Johnson’s production schedule.

These steps included providing a team of experts to oversee manufacturing and logistical support from the Department of Defense, according to White House press secretary Jen Psaki. In addition, the President will use the Defense Production Act, a law dating back to the Korean War, to give Johnson & Johnson access to supplies needed to manufacture and package vaccines.